CapitalG, Alphabet's independent growth fund, invests in remarkable companies transforming the fields of consumer products and services, enterprise tech, cybersecurity, fintech, cryptocurrency, and transportation tech. CapitalG partners with growth-stage companies in their transition from startup to scale-up through hands-on assistance from its in-house growth team and connections to Google's engineering, product, marketing, sales, and people operations experts worldwide. More than 2,500 Googlers and Alphabet leaders have already engaged with CapitalG portfolio companies, including Airbnb, Collibra, CrowdStrike, Curated, DCG, Duolingo, Freshworks, Gusto, ID.me, Lyft, Robinhood, Stripe, UiPath, Whatnot, among others.

CapitalG

Redpoint has partnered with visionary founders to create new markets and redefine existing ones since 1999. The firm invests in startups across seed, early, and growth phases. In total, Redpoint manages $4 billion across multiple funds.

Redpoint

New Enterprise Associates is a prominent venture capital firm focusing on investments in technology and healthcare startups. They help entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from the seed stage through the IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

New Enterprise Associates

AHV was established in 2001 by Ascension Health with a commitment of $125 million to invest in expansion- to late-stage healthcare companies. Ascension Health is the nation's largest Catholic and largest nonprofit health system serving patients through a network of hospitals and health facilities in 20 states and the District of Columbia. AHV offers its limited partners the ability to earn venture-level financial returns while providing early insight to future healthcare developments.

Ascension Ventures

Echo Health Ventures is a venture capital firm that focuses on investing in health care companies. From offices in Durham, Portland, and Seattle, Echo Health Ventures invests in health care companies. They work with portfolio companies to accelerate their innovations to scale nationally. As stage-agnostic investors, they are committed to a new approach to strategic investing – an approach that brings more than capital to the table, an approach focused on developing deep, high-value relationships with their portfolio companies.

Echo Health Ventures

Town Hall Ventures is an investment firm aimed at transforming the woefully broken U.S. health care market through technology. It is dedicated to working side-by-side with visionary entrepreneurs who want to transform care delivery and health outcomes for the most underserved and higher need populations across the country. Town Hall seeks to invest in and support the best entrepreneurs - those bold enough to want to change the system and impact millions of lives.

Town Hall Ventures

Oxeon is an executive search and venture firm partnering with impactful growth stage healthcare businesses to solve our nation’s most complex challenges. We connect our healthcare company partners with the fundamental drivers of business growth: great people, transformational business development partnerships, strategic investments, next generation business ideas, as well as various advisory and other growth-related services. Oxeon's foundation is built on our deep relationships with leading companies and executives in healthcare IT and services. Through these relationships, we: - find the right leaders to drive business growth for our clients - connect companies across our network to build business - translate insights about unmet industry needs into new companies or products - invest at every step to ensure our interests are aligned with our clients and partners

Oxeon Partners

CVS Health Ventures is a dedicated corporate venture capital fund that invests in and partners with high-potential, early-stage companies that strive to make health care more accessible, affordable, and better.

CVS Health Ventures

Strive Health

Strive Health is a built-for-purpose company working with innovative payers and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-level engagement through dialysis. Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures.

Strive is a chronic disease management platform that provides primary care providers and nephrologists with solutions designed to slow the progression of kidney disease. Services offered by the company include personalized care plans, home dialysis services, transplant coordination, and a team of care managers. The company claims its value-based care approach has led to significant improvements, including a 20% reduction in the total cost of kidney care, a 42% reduction in hospitalizations, and a 94% overall patient satisfaction rate.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Strive Health Now Serves Patients in All 50 States

Strive is an AI-powered chronic disease management platform that provides primary care providers and nephrologists with solutions designed to slow the progression of kidney disease. Services offered by the company include personalized care plans, home dialysis services, transplant coordination, and a team of care managers.Funding and financialsIn <a href="https://sp-edge.com/updates/19002">May 2023 </a>, the company raised USD 166 million in a Series C funding round led by NEA and CVS Health Ventures.t. The funds were used to expand partnerships with payors, health systems, and physicians, as well as to grow and scale the business in new markets.

Strive is a chronic disease management platform that provides primary care providers and nephrologists with solutions designed to slow the progression of kidney disease. Services offered by the company include personalized care plans, home dialysis services, transplant coordination, and a team of care managers. The company claims its value-based care approach has led to significant improvements, including a 20% reduction in the total cost of kidney care, a 42% reduction in hospitalizations, and a 94% overall patient satisfaction rate.Strive uses a machine learning platform, CareMultiplier, to analyze patient data, identify the stage of kidney disease, and predict the probability of disease progression. This enables the company to provide interventions tailored to each patient's needs.Key customers and partnershipsAs of March 2024, the company had provided care for over 100,000 patients across 34 states and had partnered with over 700 nephrology providers.In <a href="https://strivehealth.com/news/humana-and-strive-health-announce-expansion-of-holistic-patient-centered-care-for-people-with-kidney-disease/">March 2024</a>, the company partnered with Humana to provide a value-based care multi-state agreement for members. Furthermore, in <a href="https://sp-edge.com/updates/21341">August 2023</a>, Strive Health partnered with Oak Street Health to provide treatment for patients affected by severe chronic kidney disease (CKD).Funding and financialsIn<a href="https://sp-edge.com/updates/19002"> May 2023</a>, the company raised USD 166 million in a Series C funding round led by NEA and CVS Health Ventures. The funds were used to expand partnerships with payors, health systems, and physicians, as well as to grow and scale the business in new markets.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

Oak Street Health has partnered with Strive Health to offer treatment to patients with severe chronic kidney disease (CKD). The collaboration combines Strive's expertise in value-based kidney care with Oak Street Health's clinical care model for older adults on Medicare. The goal is to provide specialized population health capabilities and resources to help individuals with CKD delay disease progression and improve their quality of life. Strive Health's CareMultiplier technology will be utilized to collect data, assess disease progression, and make predictions about a patient's condition.

Strive Health

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless